Kai Wärn, President and CEO: “2016 has started in line with our expectations with pre-season demand slightly higher than last year. The operating income continued to be positively impacted by favorable product mix development as well as a successful execution of efficiency improvements and cost reductions. All in all, the operational improvements have more than offset the currency headwind of around SEK -215m as well as the additional costs related to profitable growth initiatives. The operating income increased with SEK 54m to SEK 1,166m (1,112) for the first quarter and the operating margin improved to 10.3% (10.2). Sales in the Husqvarna Division increased 4% adjusted for currency, with a continued strong sales trend for robotic lawn mowers. The favorable product mix development was offset by adverse currency impact, and consequently the operating income was somewhat lower at SEK 844m (897). The Gardena Division is off to a strong start of the year with sales growing 17% adjusted for currency. Demand was driven by low retail trade inventory levels following the strong end of last year’s season and our growth ambitions in respect of geography, channel and new product introductions such as the Gardena Smart Garden. Operating income for the division rose to SEK 226m (204). Consumer Brands continued to focus on their turn-around. Several important steps have been taken and encouraging signs were seen in the first quarter. Sales stabilized after prior year’s decline which was driven by the value before volume strategy. Operating income rose to SEK 64m (-11) with a corresponding margin of 1.9% (-0.3), despite unfavorable currency impact of almost SEK -55m. The Construction division continued to capitalize on its market leading portfolio of products and services, as well as the recent investments in market and sales structure. Growth in the first quarter was 6% adjusted for currency, resulting in an increase of operating income to SEK 89m (74) and the corresponding margin widening to 9.2% (8.0). The priority for the Group during the remainder of the year will be to offset both the currency headwind and to finance the profitable growth initiatives by operational improvements.” January - March 2016 · Net sales amounted to SEK 11,361m (10,928), an increase of 5% adjusted for changes in exchange rates. · Operating income improved to SEK 1,166m (1,112). · Changes in exchange rates impacted operating income negatively by around SEK -215m. · Net debt decreased to SEK 8,254m (10,172) and the net debt/equity ratio improved to 0.60 (0.79). · Earnings per share decreased to SEK 1.32 (1.37). Telephone conference A combined press and telephone conference, hosted by Kai Wärn, President and CEO, and Jan Ytterberg, CFO, will be held at Husqvarna Group’s office, Regeringsgatan 28, Stockholm at 10:00 CET on April 21, 2016. To participate, please dial +46 (0) 8 5033 6434 (Sweden) or +44 (0) 8444933800 (UK) ten minutes prior to the start of the conference. The conference call will also be audio cast live on www.husqvarnagroup.com/ir (http://www.husqvarna.com/ir). A replay will be available later the same day. Contacts Jan Ytterberg, CFO, +46 8 738 90 77 Tobias Norrby, Investor Relations Manager, +46 8 738 93 35 This interim report comprises information which Husqvarna is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 08:00 CET on April 21, 2016. Husqvarna Group Husqvarna Group is a world leading producer of outdoor power products for garden, park and forest care. Products include chainsaws, trimmers, robotic lawn mowers and ride-on lawn mowers. The Group is also the European leader in garden watering products and a world leader in cutting equipment and diamond tools for the construction and stone industries. The Group’s products and solutions are sold under brands including Husqvarna, Gardena, McCulloch, Poulan Pro, Weed Eater, Flymo, Zenoah and Diamant Boart via dealers and retailers to consumers and professionals in more than 100 countries. Net sales in 2015 amounted to SEK 36 billion and the Group has more than 13,000 employees in 40 countries.
Interim report January - March 2016 Kai Wrn, President and
Top 10 Most Recent News Articles
Copper Peptides Shine in New Renue Blue Cream
Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...
Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill
Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...
Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment
Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...
Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision
Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...
Continue ReadingPeptide Tracker Refresh Unveils New Planning Features
Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...
Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth
New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...
Continue Reading
Local Bounti Expands: Acquires CEA Facilities
Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...
Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push
An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...
Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted
BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...
Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch
Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring Natural Hydrogen: MAX Power Mining's Vision
MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...
Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition
A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...
Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...
Continue Reading
Future Landscape of the UV Stabilizers Market by 2032
Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...
Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors
Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...
Continue Reading